Диссертация (Влияние компонентов сигнального пути HEDGEHOG на пролиферацию и химиорезистентность низкодифференцированных глиом), страница 26

– Vol. 37. – № 6. – P. 1192-200.183. Johannessen, T. C. Molecular mechanisms of temozolomide resistance in glioblastomamultiforme / T. C. Johannessen, R. Bjerkvig // Expert Rev Anticancer Ther. – 2012. – Vol. 12. –№ 5. – P. 635-42.184. Yoon, J. W. Defining a role for Sonic hedgehog pathway activation in desmoplasticmedulloblastoma by identifying GLI1 target genes / J. W. Yoon, R. Gilbertson, S. Iannaccone etal. // Int J Cancer. – 2009.

– Vol. 124. – № 1. – P. 109-19.185. Альбертс, Б. Молекулярная биология клетки: в 3-х томах. Т. 1 / Б. Альбертс, А. Джонсон,Д. Льюис и др. – Ижевск : НИЦ «Регулярная и хаотическая динамика», Институткомпьютерных исследований, 2013. – 808 с.186. Mazumdar, T. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNAdamage and extensive cell death in human colon carcinoma cells / T. Mazumdar, J.

Devecchio,A. Agyeman et al. // Cancer Res. – 2011. – Vol. 71. – № 17. – P. 5904-14.187. Shi, T. cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition inhuman colon cancer cells / T. Shi, T. Mazumdar, J. Devecchio et al. // PLoS One. – 2010.

– Vol.5. – № 10. – P. e13054.188. Wu, X. Y. Cyclopamine increases the radiosensitivity of human pancreatic cancer cells byregulating the DNA repair signal pathway through an epidermal growth factor receptordependentpathway / X. Y. Wu, J. Che, K. K.

Sun et al. // Mol Med Rep. – 2013. – Vol. 8. – № 4. – P. 97983.189. Leonard, J. M. Sonic Hedgehog signaling impairs ionizing radiation-induced checkpointactivation and induces genomic instability / J. M. Leonard, H. Ye, C. Wetmore et al. // J CellBiol. – 2008. – Vol. 183. – № 3. – P. 385-91.190. Elmore, S. Apoptosis: a review of programmed cell death / S. Elmore // Toxicol Pathol.

– 2007.– Vol. 35. – № 4. – P. 495-516.117191. Nolan-Stevaux, O. GLI1 is regulated through Smoothened-independent mechanisms inneoplastic pancreatic ducts and mediates PDAC cell survival and transformation / O. NolanStevaux, J. Lau, M. L. Truitt et al. // Genes Dev. – 2009. – Vol. 23. – № 1. – P. 24-36.192. Chen, X. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cellproliferation: it's inhibition leads to growth suppression and apoptosis / X. Chen, A. Horiuchi, N.Kikuchi et al.

// Cancer Sci. – 2007. – Vol. 98. – № 1. – P. 68-76.193. Chandra, V. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expressionshowing a single continuous distribution rather than discrete high/low clusters / V. Chandra, T.Das, P. Gulati et al. // PLoS One. – 2015.

– Vol. 10. – № 3. – P. e0116390.194. Bigelow, R. L. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signalingpathway through gli-1 / R. L. Bigelow, N. S. Chari, A. B. Unden et al. // J Biol Chem. – 2004. –Vol. 279. – № 2. – P. 1197-205.195. Hennessy, M. A primer on the mechanics of P-glycoprotein the multidrug transporter / M.Hennessy, J. P. Spiers // Pharmacol Res. – 2007.

– Vol. 55. – № 1. – P. 1-15.196. Dean, M. Tumour stem cells and drug resistance / M. Dean, T. Fojo, S. Bates // Nat Rev Cancer.– 2005. – Vol. 5. – № 4. – P. 275-84.197. Munoz, J. L. Temozolomide competes for P-glycoprotein and contributes to chemoresistance inglioblastoma cells / J. L. Munoz, N. D.

Walker, K. W. Scotto et al. // Cancer Lett. – 2015. – Vol.367. – № 1. – P. 69-75.198. Loo, T. W. Do drug substrates enter the common drug-binding pocket of P-glycoprotein through"gates"? / T. W. Loo, D. M. Clarke // Biochem Biophys Res Commun. – 2005. – Vol. 329. – №2. – P. 419-22.199. Borgnia, M. J. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on acommon P-glycoprotein pharmacophore as revealed by its ATPase activity / M. J. Borgnia, G. D.Eytan, Y. G. Assaraf // J Biol Chem. – 1996.

– Vol. 271. – № 6. – P. 3163-71.200. Eytan, G. D. The role of passive transbilayer drug movement in multidrug resistance and itsmodulation / G. D. Eytan, R. Regev, G. Oren et al. // J Biol Chem. – 1996. – Vol. 271. – № 22. –P. 12897-902.201. Eytan, G. D. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes frommultidrug-resistant cells is determined by their passive transmembrane movement rate / G. D.Eytan, R. Regev, G. Oren et al.

// Eur J Biochem. – 1997. – Vol. 248. – № 1. – P. 104-12.202. Sims-Mourtada, J. Sonic Hedgehog promotes multiple drug resistance by regulation of drugtransport / J. Sims-Mourtada, J. G. Izzo, J. Ajani et al. // Oncogene. – 2007. – Vol. 26. – № 38. –P. 5674-9.118203. Queiroz, K. C. Hedgehog signaling maintains chemoresistance in myeloid leukemic cells / K. C.Queiroz, R. R. Ruela-de-Sousa, G. M.

Fuhler et al. // Oncogene. – 2010. – Vol. 29. – № 48. – P.6314-22.204. Singh, R. R. ABCG2 is a direct transcriptional target of hedgehog signaling and involved instroma-induced drug tolerance in diffuse large B-cell lymphoma / R. R. Singh, K. Kunkalla, C.Qu et al. // Oncogene. – 2011. – Vol. 30. – № 49. – P. 4874-86.205. Huang, F. T. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stemcells and reverses chemoresistance / F. T. Huang, Y.

X. Zhuan-Sun, Y. Y. Zhuang et al. // Int JOncol. – 2012. – Vol. 41. – № 5. – P. 1707-14.206. Chen, Y. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1and ABCG2 in epithelial ovarian cancer / Y. Chen, M. M. Bieber, N. N. Teng // Mol Carcinog. –2014. – Vol. 53. – № 8. – P. 625-34.207. Statkiewicz, M. The role of the SHH gene in prostate cancer cell resistance to paclitaxel / M.Statkiewicz, N. Maryan, A.

Lipiec et al. // Prostate. – 2014. – Vol. 74. – № 11. – P. 1142-52.208. Mimeault, M. Inhibition of hedgehog signaling improves the anti-carcinogenic effects ofdocetaxel in prostate cancer / M. Mimeault, S. Rachagani, S. Muniyan et al. // Oncotarget. –2015. – Vol. 6. – № 6. – P. 3887-903.209. Amable, L. Gli1 contributes to cellular resistance to cisplatin through altered cellularaccumulation of the drug / L.

Amable, J. Fain, E. Gavin et al. // Oncol Rep. – 2014. – Vol. 32. –№ 2. – P. 469-74.210. Hall, M. D. The role of cellular accumulation in determining sensitivity to platinum-basedchemotherapy / M. D. Hall, M. Okabe, D. W. Shen et al. // Annu Rev Pharmacol Toxicol. –2008. – Vol. 48. – P. 495-535.211. Das, S. Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makescancer cells refractory to Smoothened-targeting Hedgehog inhibition / S. Das, R. S.

Samant, L.A. Shevde // J Biol Chem. – 2013. – Vol. 288. – № 17. – P. 11824-33.212. Munoz, J. L. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1,independent of sonic hedgehog level / J. L. Munoz, V. Rodriguez-Cruz, S. H. Ramkissoon et al.// Oncotarget. – 2015. – Vol. 6. – № 2. – P. 1190-201.213. Munoz, J. L. High expression of miR-9 in CD133+ glioblastoma cells in chemoresistance totemozolomide / J.

L. Munoz, V. Rodriguez-Cruz, P. Rameshwar // J Cancer Stem Cell Res. –2015. – Vol. 3.214. Munoz, J. L. Temozolomide resistance and tumor recurrence: Halting the Hedgehog / J. L.Munoz, V. Rodriguez-Cruz, N. D. Walker et al. // Cancer Cell Microenviron. – 2015. – Vol. 2. –№ 2.119215. Zhang, Y. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP andABCB1/Pgp / Y. Zhang, J. Laterra, M. G. Pomper // Neoplasia. – 2009. – Vol. 11.

– № 1. – P.96-101.216. Zhao, J. NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway,effectively overcomes vismodegib resistance conferred by Smo mutations / J. Zhao, H. Quan, C.Xie et al. // Pharmacol Res Perspect. – 2014. – Vol. 2. – № 3. – P. e00043.217. Zahreddine, H. A. The sonic hedgehog factor GLI1 imparts drug resistance through inducibleglucuronidation / H. A. Zahreddine, B. Culjkovic-Kraljacic, S.

Assouline et al. // Nature. – 2014.– Vol. 511. – № 7507. – P. 90-3.218. Chen, Y. J. Sonic hedgehog signaling protects human hepatocellular carcinoma cells againstionizing radiation in an autocrine manner / Y. J. Chen, C. P. Lin, M. L. Hsu et al. // Int J RadiatOncol Biol Phys. – 2011. – Vol. 80. – № 3.

– P. 851-9.219. Chiang, M. F. Modulation of Sonic hedgehog signaling and WW domain containingoxidoreductase WOX1 expression enhances radiosensitivity of human glioblastoma cells / M. F.Chiang, H. H. Chen, C. W. Chi et al. // Exp Biol Med (Maywood). – 2015. – Vol. 240. – № 3. –P. 392-9.220. Denko, N. C. Hypoxia, HIF1 and glucose metabolism in the solid tumour / N.

C. Denko // NatRev Cancer. – 2008. – Vol. 8. – № 9. – P. 705-13.221. Vander Heiden, M. G. Understanding the Warburg effect: the metabolic requirements of cellproliferation / M. G. Vander Heiden, L. C. Cantley, C. B. Thompson // Science. – 2009. – Vol.324. – № 5930.